68 results
Search Results
2. Green roof gardens – Selecting allergy friendly vegetation: a GA2LEN position paper
3. Can an Artificial Intelligence (AI) be an Author on a Medical Paper?
4. Can an Artificial Intelligence (AI) Be an Author on a Medical Paper?
5. Management of Difficult-to-Treat Atopic Dermatitis
6. Climate Change and Our Environment: The Effect on Respiratory and Allergic Disease
7. The Role of Early Life Food Sensitization in Adolescent Lung Function: Results from 2 Birth Cohort Studies
8. Chief Complaint: Nasal Congestion
9. Ockham’s Razor: The Application of Parsimonious Medicine in Allergy/Immunology
10. Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis
11. Impact of Allergic Rhinitis Control on Work Productivity and Costs: A Real-World Data MASK-air Study
12. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
13. Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts’ Perspective
14. Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease?
15. What We Mean When We Talk About Adherence in Respiratory Medicine
16. Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy
17. Cutoff Values of MASK-air Patient-Reported Outcome Measures
18. Advances in the Understanding of Drug Hypersensitivity: 2012 Through 2022
19. The Microbiome as a Gateway to Prevention of Allergic Disease Development
20. Use of technology to improve adherence in allergy/immunology.
21. How to Measure Disease Activity, Impact, and Control in Patients with Recurrent Wheals, Angioedema, or Both
22. Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine
23. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema
24. Perioperative Hypersensitivity Evaluation and Management: A Practical Approach
25. The Allergen: Sources, Extracts, and Molecules for Diagnosis of Allergic Disease
26. How Maternal BMI Modifies the Impact of Personalized Asthma Management in Pregnancy
27. Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register
28. Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies
29. Depressive symptom severity in mid- to late life in individuals with and without asthma
30. Delayed B-cell maturation and attenuated vaccine responses in infants exposed to B-cell depleting therapies in utero
31. The Seven Stages of Man: The Role of Developmental Stage on Medication Adherence in Respiratory Diseases
32. Enhancing Respiratory Medication Adherence: The Role of Health Care Professionals and Cost-Effectiveness Considerations
33. Patient-Reported Outcome Measure Development and Validation: A Primer for Clinicians
34. Summary of the Dutch multidisciplinary practice Guideline on Asthma and Pregnancy
35. Airway Obstruction Worsens in Young Adults with Asthma Who Become Obese
36. Positive Family History, Infection, Low Absolute Lymphocyte Count (ALC), and Absent Thymic Shadow: Diagnostic Clues for All Molecular Forms of Severe Combined Immunodeficiency (SCID)
37. Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis
38. Severe T-cell lymphopenia in a patient with microduplication 22q11.2 identified by newborn screening
39. Diagnostic Challenges in Anaphylaxis
40. Racial and Ethnic Disparity in Food Allergy in the United States: A Systematic Review
41. Vocal Cord Dysfunction Related to Water-Damaged Buildings
42. Controversies in Drug Allergy: Radiographic Contrast Media
43. Complete remission of eosinophilic esophagitis with multi-aeroallergen subcutaneous immunotherapy: A case report
44. The Unexpected Risks of COVID-19 on Asthma Control in Children
45. Is “Maintenance” a Misnomer? A Narrative Framework Setting the Right Expectations of Allergen Immunotherapy
46. Epinephrine Autoinjectors: New Data, New Problems
47. Artificial Intelligence Chatbots in Allergy and Immunology Practice: Where Have We Been and Where Are We Going?
48. The Art of Immunotherapy
49. Super-Responders to Biologic Treatment in Type 2–High Severe Asthma: Passing Fad or a Meaningful Phenotype?
50. Sensitization to amoxicillin/clavulanic acid may underlie severe rashes in children treated for infectious mononucleosis
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.